PL377791A1 - Pochodne 3-aminopiperydyny i sposoby ich wytwarzania - Google Patents
Pochodne 3-aminopiperydyny i sposoby ich wytwarzaniaInfo
- Publication number
- PL377791A1 PL377791A1 PL377791A PL37779103A PL377791A1 PL 377791 A1 PL377791 A1 PL 377791A1 PL 377791 A PL377791 A PL 377791A PL 37779103 A PL37779103 A PL 37779103A PL 377791 A1 PL377791 A1 PL 377791A1
- Authority
- PL
- Poland
- Prior art keywords
- amino
- processes
- preparation
- piperidine derivatives
- piperidine
- Prior art date
Links
- PEUGKEHLRUVPAN-UHFFFAOYSA-N piperidin-3-amine Chemical class NC1CCCNC1 PEUGKEHLRUVPAN-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4462—Non condensed piperidines, e.g. piperocaine only substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42832402P | 2002-11-21 | 2002-11-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL377791A1 true PL377791A1 (pl) | 2006-02-20 |
Family
ID=32326635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL377791A PL377791A1 (pl) | 2002-11-21 | 2003-11-10 | Pochodne 3-aminopiperydyny i sposoby ich wytwarzania |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7084277B2 (pl) |
| EP (1) | EP1572649A2 (pl) |
| JP (1) | JP2006508976A (pl) |
| KR (2) | KR100678800B1 (pl) |
| CN (2) | CN101353321A (pl) |
| AU (1) | AU2003278529A1 (pl) |
| BR (1) | BR0316470A (pl) |
| CA (1) | CA2506016C (pl) |
| MX (1) | MXPA05005403A (pl) |
| PL (1) | PL377791A1 (pl) |
| RS (1) | RS20050380A (pl) |
| RU (2) | RU2309147C9 (pl) |
| WO (1) | WO2004046112A2 (pl) |
| ZA (1) | ZA200504068B (pl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1382339E (pt) | 1999-12-10 | 2008-02-06 | Pfizer Prod Inc | Composições que contêm derivados de pirrolo[2,3-d]- pirimidina |
| TWI329105B (en) | 2002-02-01 | 2010-08-21 | Rigel Pharmaceuticals Inc | 2,4-pyrimidinediamine compounds and their uses |
| HRP20050089B1 (hr) | 2002-07-29 | 2015-06-19 | Rigel Pharmaceuticals | Upotreba 2,4 pirimidindiaminskog spoja za proizvodnju lijeka za lijeäśenje ili sprjeäśavanje autoimunosne bolesti |
| JP4886511B2 (ja) | 2003-07-30 | 2012-02-29 | ライジェル ファーマシューティカルズ， インコーポレイテッド | ２，４−ピリミジンジアミン化合物による自己免疫疾患の治療または予防方法 |
| KR20070006889A (ko) * | 2004-05-03 | 2007-01-11 | 노파르티스 아게 | Ｓ1ｐ 수용체 작용제 및 ｊａｋ3 키나제 억제제를 포함하는조합물 |
| AU2006254840B2 (en) | 2005-06-08 | 2012-08-02 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
| US20070203161A1 (en) | 2006-02-24 | 2007-08-30 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the jak pathway |
| CA2614907C (en) | 2005-07-29 | 2012-02-28 | Pfizer Products Inc. | Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
| ES2622493T3 (es) | 2006-02-24 | 2017-07-06 | Rigel Pharmaceuticals, Inc. | Composiciones y métodos para la inhibición de la ruta de JAK |
| US8193197B2 (en) | 2006-10-19 | 2012-06-05 | Rigel Pharmaceuticals, Inc. | Compositions and methods for inhibition of the JAK pathway |
| WO2009103032A1 (en) | 2008-02-15 | 2009-08-20 | Rigel Pharmaceuticals, Inc. | Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| MX2010011463A (es) | 2008-04-16 | 2011-06-03 | Portola Pharm Inc | 2,6-diamino-pirimidin-5-il-carboxamidas como inhibidores de syk o jak quinasas. |
| US8138339B2 (en) | 2008-04-16 | 2012-03-20 | Portola Pharmaceuticals, Inc. | Inhibitors of protein kinases |
| JP2011518219A (ja) | 2008-04-22 | 2011-06-23 | ポートラ ファーマシューティカルズ， インコーポレイテッド | タンパク質キナーゼの阻害剤 |
| CN101565397B (zh) * | 2009-04-07 | 2011-08-10 | 浙江医药股份有限公司新昌制药厂 | N-Boc-3-氨基哌啶及其光学异构体的合成方法 |
| CA3025627C (en) | 2009-04-20 | 2021-08-31 | Auspex Pharmaceuticals, Inc. | Piperidine inhibitors of janus kinase 3 |
| EA201290147A1 (ru) | 2009-10-15 | 2012-11-30 | Пфайзер Инк. | Пирроло[2,3-d]пиримидиновые соединения |
| CA2781716A1 (en) * | 2009-12-04 | 2011-06-09 | Sunovion Pharmaceuticals Inc. | Multicyclic thieno compounds and use thereof for the treatment of a neurological disorder |
| WO2011075334A1 (en) | 2009-12-18 | 2011-06-23 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidine compounds |
| WO2011097087A1 (en) | 2010-02-05 | 2011-08-11 | Pfizer Inc. | Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors |
| WO2012061428A2 (en) | 2010-11-01 | 2012-05-10 | Portola Pharmaceuticals, Inc. | Nicotinamides as jak kinase modulators |
| SG11201402570QA (en) | 2011-11-23 | 2014-06-27 | Portola Pharm Inc | Pyrazine kinase inhibitors |
| CN104837817B (zh) | 2012-07-25 | 2017-03-22 | 力奇制药公司 | 制备3‑氨基‑哌啶化合物的合成路线 |
| RU2499793C1 (ru) * | 2012-08-24 | 2013-11-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Волгоградский государственный технический университет" (ВолгГТУ) | Способ получения третичных аминов |
| WO2014058921A2 (en) | 2012-10-08 | 2014-04-17 | Portola Pharmaceuticals, Inc. | Substituted pyrimidinyl kinase inhibitors |
| US9481679B2 (en) * | 2012-12-17 | 2016-11-01 | Sun Pharmaceutical Industries Limited | Process for the preparation of tofacitinib and intermediates thereof |
| RS58245B1 (sr) | 2013-02-22 | 2019-03-29 | Pfizer | Kombinacija derivata pirolo[2,3-d]pirimidina sa jednim ili više dodatnih sredstava kao inhibitor janus kinaza (jak) |
| WO2015083028A1 (en) | 2013-12-05 | 2015-06-11 | Pfizer Inc. | Pyrrolo[2,3-d]pyrimidinyl, pyrrolo[2,3-b]pyrazinyl and pyrrolo[2,3-d]pyridinyl acrylamides |
| CN103755624B (zh) * | 2014-01-20 | 2018-10-09 | 上海博氏医药科技有限公司 | 一种哌啶衍生物的合成方法 |
| EP3180344B1 (en) | 2014-08-12 | 2019-09-18 | Pfizer Inc | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase |
| ES2928757T3 (es) | 2015-05-01 | 2022-11-22 | Pfizer | Acrilamidas de pirrolo[2,3-b]pirazinilo y epóxidos de las mismas como inhibidores de la Janus Quinasa |
| EP3421455B1 (en) * | 2017-06-29 | 2019-03-27 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of chiral 3-amino-piperidins, useful intermediates for the preparation of tofacitinib |
| CA3091292A1 (en) | 2018-02-16 | 2019-08-22 | Sunovion Pharmaceuticals Inc. | Salts, crystal forms, and production methods thereof |
| EP3946606B1 (en) | 2019-03-27 | 2025-01-01 | Insilico Medicine IP Limited | Bicyclic jak inhibitors and uses thereof |
| CN115734785A (zh) | 2020-04-14 | 2023-03-03 | 桑诺维恩药品公司 | (S)-(4,5-二氢-7H-噻吩并[2,3-c]吡喃-7-基)-N-甲基甲胺用于治疗神经和精神方面的病症 |
| KR102897364B1 (ko) * | 2024-03-19 | 2025-12-05 | 인천대학교 산학협력단 | 아실하이드라지드 화합물로부터 옥사다이아진 화합물의 원포트 합성방법 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE640616A (pl) * | 1962-12-19 | |||
| US3492397A (en) * | 1967-04-07 | 1970-01-27 | Warner Lambert Pharmaceutical | Sustained release dosage in the pellet form and process thereof |
| US4060598A (en) * | 1967-06-28 | 1977-11-29 | Boehringer Mannheim G.M.B.H. | Tablets coated with aqueous resin dispersions |
| US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
| US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
| JPS59112984A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | １，４−ベンゾジアゼピン誘導体 |
| US4725599A (en) * | 1986-09-08 | 1988-02-16 | Pfizer Inc. | Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial agents |
| FR2619111B1 (fr) * | 1987-08-07 | 1991-01-11 | Synthelabo | Derives de (piperidinyl-4)methyl-2 tetrahydro-1,2,3,4 9h-pyrido (3,4-b) indole, leur preparation et leur application en therapeutique |
| NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| BR9205807A (pt) * | 1991-03-26 | 1994-06-28 | Pfizer | Preparação estéreo-seletiva de piperidinas substituidas |
| US5461156A (en) * | 1993-03-31 | 1995-10-24 | Eli Lilly And Company | Stereocontrolled synthesis of cis-bicyclic compounds |
| US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
| EP0942732B1 (en) * | 1996-12-02 | 2004-11-17 | MERCK SHARP & DOHME LTD. | Use of nk-1 receptor antagonists for treating movement disorders |
| EP0991622A1 (en) * | 1997-06-27 | 2000-04-12 | MERCK SHARP & DOHME LTD. | Substituted 3-(benzylamino)piperidine derivatives and their use as therapeutic agents |
| ATE423776T1 (de) | 1997-09-15 | 2009-03-15 | Procter & Gamble | Antimikrobielle chinolone, ihre zusammensetzungen und ihre verwendungen |
| JP4030164B2 (ja) * | 1997-12-01 | 2008-01-09 | 株式会社トクヤマ | テトラハイドロピリジン誘導体及びその製造方法 |
| PT1382339E (pt) * | 1999-12-10 | 2008-02-06 | Pfizer Prod Inc | Composições que contêm derivados de pirrolo[2,3-d]- pirimidina |
| SK13072002A3 (sk) * | 2000-03-17 | 2003-08-05 | Bristol-Myers Squibb Pharma Company | Deriváty cyklických beta-aminokyselín ako inhibítory matrixových metaloproteáz a TNF-alfa |
| MY145722A (en) * | 2000-04-27 | 2012-03-30 | Abbott Lab | Diazabicyclic central nervous system active agents |
| JP3771128B2 (ja) * | 2000-12-28 | 2006-04-26 | 独立行政法人科学技術振興機構 | フェブリフジンおよびフェブリフジン化合物の新規合成方法 |
| WO2002057244A1 (en) * | 2001-01-19 | 2002-07-25 | Cytokinetics, Inc. | Phenothiazine kinesin inhibitors |
-
2003
- 2003-11-10 KR KR1020057009058A patent/KR100678800B1/ko not_active Expired - Fee Related
- 2003-11-10 RU RU2005115500/04A patent/RU2309147C9/ru active
- 2003-11-10 CN CNA2008101292567A patent/CN101353321A/zh active Pending
- 2003-11-10 EP EP03769829A patent/EP1572649A2/en not_active Withdrawn
- 2003-11-10 WO PCT/IB2003/005151 patent/WO2004046112A2/en not_active Ceased
- 2003-11-10 JP JP2004553003A patent/JP2006508976A/ja not_active Withdrawn
- 2003-11-10 AU AU2003278529A patent/AU2003278529A1/en not_active Abandoned
- 2003-11-10 PL PL377791A patent/PL377791A1/pl not_active Application Discontinuation
- 2003-11-10 KR KR1020067021730A patent/KR100742012B1/ko not_active Expired - Fee Related
- 2003-11-10 BR BR0316470-5A patent/BR0316470A/pt not_active IP Right Cessation
- 2003-11-10 CA CA002506016A patent/CA2506016C/en not_active Expired - Fee Related
- 2003-11-10 MX MXPA05005403A patent/MXPA05005403A/es active IP Right Grant
- 2003-11-10 RS YUP-2005/0380A patent/RS20050380A/sr unknown
- 2003-11-10 CN CNA2003801062274A patent/CN1726192A/zh active Pending
- 2003-11-20 US US10/717,958 patent/US7084277B2/en not_active Expired - Fee Related
-
2005
- 2005-05-19 ZA ZA200504068A patent/ZA200504068B/en unknown
-
2007
- 2007-04-28 RU RU2007116248/04A patent/RU2007116248A/ru not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20060116873A (ko) | 2006-11-15 |
| US20040102627A1 (en) | 2004-05-27 |
| RU2005115500A (ru) | 2006-01-20 |
| MXPA05005403A (es) | 2005-08-03 |
| KR100742012B1 (ko) | 2007-07-23 |
| CA2506016C (en) | 2009-03-17 |
| RU2309147C2 (ru) | 2007-10-27 |
| CA2506016A1 (en) | 2004-06-03 |
| BR0316470A (pt) | 2005-10-11 |
| ZA200504068B (en) | 2006-08-30 |
| RU2309147C9 (ru) | 2008-03-20 |
| RU2007116248A (ru) | 2008-11-10 |
| WO2004046112A3 (en) | 2004-08-05 |
| RS20050380A (sr) | 2007-11-15 |
| CN101353321A (zh) | 2009-01-28 |
| AU2003278529A1 (en) | 2004-06-15 |
| WO2004046112A2 (en) | 2004-06-03 |
| CN1726192A (zh) | 2006-01-25 |
| KR20050083905A (ko) | 2005-08-26 |
| US7084277B2 (en) | 2006-08-01 |
| JP2006508976A (ja) | 2006-03-16 |
| EP1572649A2 (en) | 2005-09-14 |
| KR100678800B1 (ko) | 2007-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL377791A1 (pl) | Pochodne 3-aminopiperydyny i sposoby ich wytwarzania | |
| IL215617A0 (en) | Substituted pyrrolo-pyrazole derivatives and process for their preparation | |
| IL189658A0 (en) | N-phenyl-2-pyrimidine-amine derivatives | |
| IL163691A0 (en) | 5-Pphenylthiazole derivatives and use as pi3 kinase | |
| EG24050A (en) | Heterocylocarboxamide derivatives | |
| IL165226A0 (en) | Spiroindolinepiperidine derivatives | |
| PL374718A1 (pl) | Azolidynono-winylowe pochodne skondensowanego benzenu | |
| IL166121A0 (en) | Indole-3-sulphur derivatives | |
| EP1522540A4 (en) | AZAARENE DERIVATIVES | |
| AU2003284001A8 (en) | Triazolone and triazolethione derivatives | |
| PL376475A1 (pl) | Pochodne N-podstawionej 2-oksodihydropirydyny | |
| AU2003232650A1 (en) | N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof | |
| IL163868A0 (en) | Hermiasterlin derivatives and uses thereof | |
| IL166426A0 (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
| IL170313A (en) | Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them | |
| AU2003296369A8 (en) | Imminoamines and preparation thereof | |
| EP1487799A4 (en) | 9-AMINOACRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF | |
| TWI340745B (en) | Novel diketopiperazine derivatives and the processes for preparation thereof | |
| PL374761A1 (pl) | Pochodne N-benzodioksolilo, N-benzodioksanylo i N-benzodioksepinylo arylokarboksyamidu oraz kompozycje farmaceutyczne, zawierające takie pochodne | |
| AU2003222659A8 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
| GB2411378B (en) | Droplet-deposition related methods and appparatus | |
| AU2003297612A8 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
| AU2003281698A8 (en) | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof | |
| GB0316910D0 (en) | Fluorocombretastatin and derivatives thereof | |
| HUP0401162A3 (en) | Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |